Sanofi Drug Shows Promise Against Prostate Cancer

By: Marilynn Marchione / AP Medical Writer
By: Marilynn Marchione / AP Medical Writer

A study suggests that an experimental drug may modestly extend the lives of men with advanced prostate cancer who are no longer responding to other treatments.

The drug, cabazitaxel (kuh-BAH-zuh-TAX-uhl), helped men live an average of 10 weeks longer in a large study sponsored by the drug's maker, Sanofi-Aventis. Researchers hope the drug can make more of a difference in men who aren't so sick. The federal Food and Drug Administration has said it will give the drug fast review.

You must be logged in to post comments.

Password (case sensitive):
Remember Me:
8195 Front Beach Road Panama City Beach, FL 32407 Station: 850-234-7777 News: 850-230-5221 Fax: 850-233-6647
Copyright © 2002-2016 - Designed by Gray Digital Media - Powered by Clickability 86332157 -
Gray Television, Inc.